NorthX Biologics enters as a partner in AdBIOPRO, Competence Centre for Advanced BioProduction
NorthX Biologics is proud to have the opportunity to support and be a part of AdBIOPRO. “It is a great infrastructure for ground breaking research and development aimed at finding solutions to some of the manufacturing challenges that need a resolution in order to bring advanced therapies to the patients at an affordable cost,” says Ola Tuvesson CTO at NorthX Biologics and member of the AdBIOPRO Centre Board.
Link to the press release: https://www.kth.se/adbiopro/news/adbiopro-competence-centre-for-advanced-bioproduction-secures-112-mkr-funding-1.1252385
About NorthX Biologics AB
NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.
For more news, follow us on LinkedIn
